🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Asian Stocks Down, COVID Variants Continue to Spread

Published 07/08/2021, 10:19 PM
Updated 07/08/2021, 10:27 PM
© Reuters.
AXJO
-
JP225
-
HK50
-
STT
-
PFE
-
KS11
-
SSEC
-
SZI
-
22UAy
-

By Gina Lee

Investing.com – Asia Pacific stocks were down Friday morning as concerns continue to mount about the spread of COVID-19 variants.

China’s Shanghai Composite inched down 0.05% by 10:14 PM ET (2:14 AM GMT) and the Shenzhen Component fell 1.14%. Data released earlier in the day said that the consumer price index (CPI) grew a smaller-than-expected 1.1% year-on-year in June, while contracting a bigger-than-expected 0.4% month-on-month.

The producer price index (PPI) grew 8.8% year-on-year, slightly down from the 9% growth seen in May.

Hong Kong’s Hang Seng Index was down 0.28%.

Japan’s Nikkei 225 fell 1.83%. Rising numbers of COVID-19 cases prompted the government to declare a fresh state of emergency in Tokyo, less than three weeks before the Tokyo Olympic Games are due to open.

The KOSPI slid 1.90% as a record number of COVID-19 cases also prompted neighboring South Korea to move social distancing rules to the top level of 4 for Seoul. The measures will take effect on Jul. 12 and are set to last for two weeks.

In Australia, the ASX 200 fell 1.24%.

U.S. government bonds mostly held their advance within the past week. However, the 30-year Treasury yield dropped below 1.90% for the first time since February 2021 during the previous session.

Inflation expectations slid further and investors digested the Chinese data.

“Reflation requires not only the continual increase in growth, there is a fiscal component to it and we’re seeing how hard it is to get some of that fiscal impulse to carry through,” State Street Corp. (NYSE:STT  global macro strategist Marvin Loh told Bloomberg.

“Monetary policy continues to drive a lot of the excess growth, and we know what that story looks like, which is lower yields,” he added.

Stimulus measures from central banks remain on investors’ radar over growing concerns that the global economic recovery from COVID-19 is slowing down. While the U.S. Federal Reserve’s minutes from its June policy meeting, released earlier in the week, said it is taking steps to prepare for asset tapering, its European counterpart seems to be taking the opposite approach.

The European Central Bank (ECB) released the results of an 18-month review on Thursday, in which the central bank raised its inflation target to 2% and said moderate overshoots would be tolerated. Group of 20, or G20, finance ministers and central bankers will meet in Venice later in the day.

Investors also remain focused on China, after the State Council earlier in the week that the People's Bank of China could cut its reserve requirement ratio for banks in an unexpected U-turn. In addition to weaker-than-expected data released earlier in the month, there are signs that the economic recovery in the world’s second-largest economy is also slowing down.

On the COVID-19 front, Pfizer Inc. (NYSE:PFE) will request FDA emergency use authorization for a third booster dose of its COVID-19 vaccine co-developed with BioNTech SE (F:22UAy). The companies are confident that the booster shot will offer protection against the Delta variant of the virus.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.